‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because ...

In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...

The field of cancer research is rapidly evolving, with a growing focus on the intersection of cancer immunology, gene editing, and epigenetics. This ...

If successful, this gene editing approach could offer hope to thousands of individuals ... About IOB At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and ...

Metagenomi says it hopes to start clinical trials next year to test MGX-001, its gene-editing therapy candidate for ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

The work has been reported in Nature Communications. SPLICER is a modification of the well known gene-editing technique known as CRISPR, in which a guide RNA takes a DNA-cutting enzyme called Cas9 to ...

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular ...

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...